Genetic mutations cause a group of rare intestinal diseases called congenital diarrheal disorders (CDD).
In a study published in the Journal of Clinical Investigation, Robert Farese and colleagues at the University of California, San Francisco, identified a family with two of three children affected by CDD. The affected children both carried a rare mutation in the DGAT1 gene. DGAT1 mediates the formation of triglycerides and is being assessed as a therapeutic target in the treatment of obesity. The study by Farese's group suggests that targeting of DGAT1 could cause a severe diarrheal disorder.
DGAT1 mutation is linked to a congenital diarrheal disorder
Robert Farese, Jr.
University of California, San Francisco, San Francisco, CA, USA
Phone: 415-734-2000; Fax: 415-355-0960;
P Type of Toilet Training Method Not Linked With Urinary Accidents in Children Combining HER2-Inhibiting Drug With Angiogenesis Inhibitor Improves Outcomes for Breast Cancer Patients With Brain Metastases M
You May Also Like